Royal Philips NV’s $1.1 billion settlement of US lawsuits targeting 5.5 million recalled sleep-apnea devices resolves only ...

In a statement, Philips said it does not admit any wrongdoing but chose to settle "to end the uncertainty associated with ...

Philips Respironics announced that it agreed to pay over a billion dollars to settle claims stemming from the 2021 U.S.

Dutch medical device maker Philips says it's reached a $1.1 billion deal in the United States to settle lawsuits over faulty ...

It's possible that the interrupted breathing and lowered oxygen levels of apnea might be harming the brain It's not yet known ...

Dutch manufacturer Philips has agreed to pay $1.1 billion to settle lawsuits regarding some models of its devices to treat ...

Could not download required scripts. Please update your browser or turn off ad blocker to continue to watch.

Findings provide further insight into the complex relationship between sleep disorders and epilepsy ...

Royal Philips NV shares soared by a record after a lower-than-expected settlement on US claims linked to faulty sleep apnea ...

A new clinical trial from drugmaker Eli Lilly shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms.

Eli Lilly reported its phase 3 clinical trial data that showed showed significant reduction in sleep apnea symptoms in people ...

Dutch healthcare company Philips says it has completed remediation of its faulty sleep therapy devices in India, asserting ...